High-sensitivity C-reactive protein levels in cerebrospinal fluid and serum in severe head injury: Relationship to tumor necrosis factor-α and interleukin-6

Journal of Clinical Neuroscience

Volumn 14, Issue 12, 2007, Pages 1163-1171

  Is, Merih ^a   Coskun, Abdurrahman ^a   Sanus, Galip Zihni ^b   Tanriverdi, Taner ^b   Kafadar, Ali Metin ^b   Hanimoglu, Hakan ^b   Tanriover, Necmettin ^b   Gezen, Ferruh ^a   Uzan, Mustafa ^b  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

hsCRP; IL 6; Inflammation; Severe head injury; TNF

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLASGOW COMA SCALE; HEAD INJURY; HUMAN; INFLAMMATION; MALE; NORMOTENSIVE HYDROCEPHALUS; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CRANIOCEREBRAL TRAUMA; FEMALE; GLASGOW COMA SCALE; HUMANS; HYDROCEPHALUS, NORMAL PRESSURE; INTERLEUKIN-6; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 36049009328     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2006.05.020     Document Type: Article

References (37)

1. Jennett B. Epidemiology of head injury. J Neurol Neurosurg Psychiatry 60 (1993) 5-11
2. Marshall L.F., Gautille T., Klauber M.R., et al. The outcome of severe closed head injury. J Neurosurg 75 (1991) 28-36
3. Tarkowski E., Rosengren L., Blomstrand C., et al. Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol 110 (1997) 492-499
4. Taupin V., Toulmond S., Serrano A., et al. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J Neuroimmunol 42 (1993) 177-185
5. Arand M., Melzner H., Kinzl L., et al. Early inflammatory mediator response following isolated traumatic brain injury and other major trauma in humans. Langenbeck's Arch Surg 386 (2001) 241-248
6. Chiaretti A., Genovese O., Aloe L., et al. Interleukin 1β and interleukin 6: relationship with paediatric head trauma severity and outcome. Childs Nerv Syst 21 (2005) 185-193
7. Csuka E., Morganti-Kossmann M.C., Lenzlinger P.M., et al. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-α, TGF-β1 and blood-brain barrier function. J Neuroimmunol 101 (1999) 211-221
8. Gruol D.L., and Nelson T.E. Physiological and pathological roles of IL-6 in the central nervous system. Mol Neurobiol 15 (1997) 307-339
9. Hans V.H.J., Kossmann T., Joller H., et al. Interleukin-6 and its soluble receptor in serum and cerebrospinal fluid after cerebral trauma. Neuroreport 10 (1999) 409-412
10. Hayakata T., Shiozaki T., Tasaki O., et al. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock 22 (2004) 102-107
11. Winter C.D., Pringle A.K., Clough G.F., et al. Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury. Brain 127 (2004) 315-320
12. Hang C.H., Shi J.X., Li J.S., et al. Expressions of intestinal NF-κB, TNF-α, and IL-6 following traumatic brain injury in rats. J Surg Res 123 (2003) 188-193
13. Knoblach S.M., Fan L., and Faden A.I. Early neuronal expression of tumor necrosis factor-α after experimental brain injury contributes to neurological impairment. J Neuroimmunol 95 (1999) 115-125
14. Sandhir R., Puri V., Klein R.M., et al. Differential expression of cytokines and chemokines during secondary neuron death following brain injury in old and young mice. Neurosci Lett 369 (2004) 28-32
15. Stover J.F., Schöning B., Beyer T.F., et al. Temporal profile of cerebrospinal fluid glutamate, interleukin-6, and tumor necrosis factor-α in relation to brain edema and contusion following controlled cortical impact injury in rats. Neurosci Lett 288 (2000) 25-28
16. Swartz K.R., Liu F., Sewell D., et al. Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res 896 (2001) 86-95
17. Kossmann T., Hans V., Imhof H.G., et al. Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res 713 (1996) 143-152
18. Pober J.S., and Cotran R.S. Cytokines and endothelial cell biology. Physiol Rev 70 (1990) 427-451
19. Chang C.Y., Chen J.Y., Ke D., et al. Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits. Nutrition 21 (2005) 987-993
20. Hoshi T., Kitagawa K., Yamagami H., et al. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 36 (2005) 768-772
21. Marquardt L., Ruf A., Mansmann U., et al. Inflammatory response after acute ischemic stroke. J Neurol Sci 236 (2005) 65-71
22. Tamam Y., Iltumur K., and Apak I. Assessment of acute phase proteins in acute ischemic stroke. Tohoku J Exp Med 206 (2005) 91-98
23. Blake G.J., and Ridker P.M. C-reactive protein: a surrogate risk marker or mediator of atherothrombosis. Am J Physiol 285 (2003) R1250-R1252
24. Jialal I., and Deveraj S. Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker. Am J Clin Pathol 116 Suppl (2001) S108-S115
25. Libby P., and Ridker P.M. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 116 Suppl 6A (2004) 9S-16S
26. Gerdes L.U., Jorgensen P.E., Nexo E., et al. C-reactive protein and bacterial meningitis: a meta-analysis. Scand J Clin Lab Invest 58 (1998) 383-393
27. Byl B., Deviere J., Saint-Hubert F., et al. Evaluation of tumor necrosis factor-alpha, interleukin-6 and C-reactive protein plasma levels as predictors of bacteremia in patients presenting signs of sepsis without shock. Clin Microbiol Infect 3 (1997) 306-316
28. Thompson D., Pepys M.B., and Wood S.P. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7 (1999) 169-177
29. Ganapathi M.K., Rzewnicki D., Samols D., et al. Effects of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep3B cells. J Immunol 147 (1991) 1261-1268
30. Mackiewicz A., Speroff T., Ganapathi M.K., et al. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 146 (1991) 3032-3037
31. Shiozaki T., Hayakata T., Tasaki O., et al. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock 23 (2005) 406-410
32. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 364 (2004) 937-952
33. Jialal I., Devaraj S., and Venugopal S.K. C-reactive protein risk marker or mediator in atherothrombosis. Hypertension 44 (2004) 6-11
34. Bickel C., Rupprecht H.J., Blankenberg S., et al. Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 15 (2002) 901-908
35. Vainas T., Stassen F.R., de Graaf R., et al. C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events. J Vasc Surg 42 (2005) 243-251
36. Cesari M., Penninx B.W., Newman A.B., et al. Inflammatory markers and onset of cardiovascular events: results from the health ABC study. Circulation 108 (2003) 2317-2322
37. Ridker P.M., Rifai N., Stampfer M.J., et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772